Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2002
08/20/2002US6436923 Compounds and methods for modulation of estrogen receptors
08/20/2002US6436909 Antisense inhibition of transforming growth factor-β expression
08/20/2002US6436907 Adenovirus-medicated gene transfer to cardiac and vascular smooth muscle
08/20/2002US6436686 Isolated microtubule motor protein having microtubule stimulated adenosine triphosphatase activity and having greater than 90% amino acid sequence identity to specified sequence as measured using sequence comparison algorithm
08/20/2002US6436670 Gene and uses therefor
08/20/2002US6436431 Fortified rice bran food product and method for promoting cardiovascular health
08/20/2002US6436397 Reducing autodegradation during processing and purification. lyophilized solutioni with bulking agent, sucrose, trehalose, or raffinose
08/20/2002US6436393 Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof
08/20/2002US6436366 Detecton, treatment and monitoring the patient with poor wound healing ability due to diabetes based on measurement of the breakdown product of nitric oxide (no) in specimens taken from the patient under controlled conditions
08/20/2002CA2240138C Quinazolin-4-one ampa antagonists
08/20/2002CA2203463C New diosmetin acids and esters, and the pharmaceutical compounds that contain them
08/20/2002CA2073983C Novel vitamin d analogues
08/20/2002CA2052041C Benzimidazole derivatives, their preparation and use
08/15/2002WO2002063308A2 Prediction of wound healing by urinary nitrate assay
08/15/2002WO2002063038A1 Method for identifying compounds modulating reverse cholesterol transport
08/15/2002WO2002063006A2 Receptors and membrane-associated proteins
08/15/2002WO2002063005A2 Lipid-associated molecules
08/15/2002WO2002063004A2 G-protein coupled receptors
08/15/2002WO2002062979A2 Enzyme
08/15/2002WO2002062970A1 Enteric nervous system derived stem and progenitor cells and uses thereof
08/15/2002WO2002062841A2 Secreted proteins
08/15/2002WO2002062810A2 Linkable sialyl lewis x analogs
08/15/2002WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors
08/15/2002WO2002062803A1 Thienopyrimidine derivative
08/15/2002WO2002062801A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension
08/15/2002WO2002062800A1 Bicyclic nitrogenous fused-ring compound
08/15/2002WO2002062799A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
08/15/2002WO2002062798A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
08/15/2002WO2002062795A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
08/15/2002WO2002062793A1 Thiazole compounds as tgf-beta inhibitors
08/15/2002WO2002062792A1 Jnk inhibitor
08/15/2002WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors
08/15/2002WO2002062788A1 Sulfonamide compounds, their preparation and use
08/15/2002WO2002062787A1 Pyrazoles as tgf inhibitors
08/15/2002WO2002062784A1 Piperidinee derivatives as neurokinin 1 antagonists
08/15/2002WO2002062780A2 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
08/15/2002WO2002062778A2 Anti-thrombotic compounds, production and use thereof as medicaments
08/15/2002WO2002062777A2 Amino ceramide-like compounds and therapeutic methods of use
08/15/2002WO2002062774A1 Thiazole derivatives for treating ppar related disorders
08/15/2002WO2002062762A2 Potassium channel openers
08/15/2002WO2002062761A1 Aminal diones as potassium channel openers
08/15/2002WO2002062751A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors
08/15/2002WO2002062750A1 Cannabinoid receptor ligands
08/15/2002WO2002062748A1 Carboxylic amides, the production and use thereof as medicaments
08/15/2002WO2002062745A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
08/15/2002WO2002062373A2 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
08/15/2002WO2002062372A2 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
08/15/2002WO2002062343A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
08/15/2002WO2002062342A1 A method for the treatment of heart failure
08/15/2002WO2002062337A1 Thiazolidinediones
08/15/2002WO2002062335A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
08/15/2002WO2002062330A2 Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs
08/15/2002WO2002062322A2 Glycine betaine and its use as anti-hemorrhagic agent
08/15/2002WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/15/2002WO2002062293A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
08/15/2002WO2002062205A2 Methods for diagnosing and treating heart disease
08/15/2002WO2002062204A2 Methods for diagnosing and treating heart disease
08/15/2002WO2002050101A8 Retinoblastoma-binding protein
08/15/2002WO2002047685A3 Nmda receptor agonist pharmaceutical compositions
08/15/2002WO2002046404A9 Schizophrenia-related voltage-gated ion channel gene and protein
08/15/2002WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/15/2002WO2002032861A3 Orally active salts with tyrosine kinase activity
08/15/2002WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses
08/15/2002WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin
08/15/2002WO2002028821A3 Propionic acid derivatives with ppar-alpha activating properties
08/15/2002WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions
08/15/2002WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition
08/15/2002WO2002026729A3 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
08/15/2002WO2002022212A8 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination
08/15/2002WO2002022160A3 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism
08/15/2002WO2002019966A3 Cardiac arrhythmia treatment methods
08/15/2002WO2002018554A3 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof
08/15/2002WO2002016381B1 Composition and method for inhibiting platelet aggregation
08/15/2002WO2002011724A3 Neuroprotective 2-pyridinamine compositions and related methods
08/15/2002WO2002002050A3 Prevention and treatment of mycoplasma-associated diseases
08/15/2002WO2002000175A3 Enhancing therapeutic effectiveness of nitric oxide inhalation
08/15/2002WO2001096307A3 Cycloalkyl alkanoic acids as integrin receptor antagonists
08/15/2002WO2001057079A3 C1 inhibitor produced in the milk of transgenic mammals
08/15/2002WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO
08/15/2002WO2001032222A9 Selective toxin expression in angiogenic endothelial cells
08/15/2002WO2001030768A9 Methods and compositions utilizing quinazolinones
08/15/2002US20020111505 Purified 15-epi-lipoxin compound has a longer tissue half-life; anticancer agents
08/15/2002US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors
08/15/2002US20020111488 Beta-substitued beta-aminoethyl phosphonate derivatives
08/15/2002US20020111383 Ultrafine L-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
08/15/2002US20020111378 Inhibitors of IMPDH enzyme
08/15/2002US20020111373 Thiadiazolidin-2,4-dione compound
08/15/2002US20020111366 Therapy for brain disorders; strokes
08/15/2002US20020111364 ABCA-1 elevating compounds
08/15/2002US20020111358 Phenoxypropylamine compounds
08/15/2002US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders
08/15/2002US20020111350 Aryl fused azapolycyclic compounds
08/15/2002US20020111347 Nervous system disorders
08/15/2002US20020111341 Bicyclic amino-pyrazinone compounds
08/15/2002US20020111333 Hypotensive agents; cardiovascular disorders
08/15/2002US20020111332 Alpha-substituted beta-aminoethyl phosphonate derivatives
08/15/2002US20020111324 Adeno-associated virus-mediated delivery of angiogenic factors
08/15/2002US20020111315 Synergistic mixture with antilipemic agent
08/15/2002US20020111306 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof
08/15/2002US20020110889 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
1 ... 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 ... 1595